首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.
【2h】

Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

机译:阿昔洛韦和异氧尿苷在树突状角膜溃疡中的随机双盲试验。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The results of a randomised double-blind clinical trial of 3% acyclovir and 0.5% idoxuridine (IDU) ophthalmic ointments in 60 patients with corneal dendritic ulceration are presented. Ulcers in all 30 patients treated with acyclovir healed compared with 22 (76%) of 29 patients treated with IDU (P < 0.01). Patients treated with acyclovir healed more rapidly (average 4.4 days) than those who received IDU (average 9.2 days) (P < 0.01). No serious side effects were observed, though transient stinging was recorded in 8 patients receiving acyclovir and in 2 patients receiving IDU. Other side effects in the IDU treated group were watering in 2 patients and superficial punctate erosions in 6 patients.
机译:介绍了60例角膜树突状溃疡患者中3%的阿昔洛韦和0.5%的艾杜糖苷(IDU)眼药膏的随机双盲临床试验结果。用阿昔洛韦治疗的所有30例患者的溃疡均得到了治愈,而使用IDU治疗的29例患者中的22例(占76%)比较(P <0.01)。阿昔洛韦治疗的患者(平均4.4天)比接受IDU治疗的患者(平均9.2天)恢复得更快(P <0.01)。没有观察到严重的副作用,尽管在接受阿昔洛韦的8例患者和接受IDU的2例患者中记录到短暂的刺激。 IDU治疗组的其他副作用是2例浇水,6例出现点状糜烂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号